Acurx Pharmaceuticals Inc.

This study tests an oral drug called ibezapolstat in 20 adults who have had three or more C. difficile infections in the past year. The goal is to see if the drug can cure the current infection and prevent future ones by targeting the bacteria while protecting healthy gut bacteri…